• ISOO Rio 2026 Post-Congress Survey

    Thank you for attending ISOO Rio 2026! Your feedback helps us improve future congresses and shape the direction of our scientific program. This survey takes approximately 7 minutes. Your responses are confidential. All results will be reviewed by the Scientific Program Committee. All fields are optional to allow you to spend time where it is most relevant to you. However, the more information you share, the more opportunity we have to improve future events.

  • SECTION 1: ABOUT YOU

  • How did you attend ISOO Rio 2026?
  • Primary area of focus - select all that apply

  • SECTION 2: SCIENTIFIC PROGRAM

  •
  • Was time allocated for Q&A adequate?

  • SECTION 3: PRESENTATION FORMATS

  • ISOO Rio featured several presentation formats. Please rate each format you attended.
  •
  • Which poster format do you prefer for future congresses?
  • Did you have enough time to view posters?

  • SECTION 4: CONGRESS FORMAT & STRUCTURE

  • As ISOO grows, we face an important decision about how to structure future congresses.

    We would value your input on the following tradeoff.

    • Option A: Fewer presentations per person (limit of 1-2 per presenter). All sessions remain in a single room, so every attendee can see every talk. Some accepted abstracts may be redirected to poster format.
    • Option B: More presentations per person (up to 3 per presenter). To accommodate the volume, sessions would run concurrently in multiple rooms. Attendees would need to choose between simultaneous sessions.
  • Which format do you prefer for future ISOO congresses?

  • At ISOO Rio, the disease topics were ordered differently across congress days compared to previous ISOO congresses.

    The two approaches are shown below.

    Rio 2026 order:

    • Pre-Day
    • Retinoblastoma
    • Melanoma
    • Non-Melanoma & Intraocular Tumors & Ocular Surface Tumors
    • Eyelid & Orbital Tumors

    Traditional ISOO order:

    • Pre-Day
    • Melanoma
    • Melanoma + Other Intraocular
    • Retinoblastoma
    • Conjunctiva & Orbit
  • Do you have a preference for how disease topics are ordered across congress days?
  • Were there enough breaks during the day?

  • SECTION 5: TOPIC COVERAGE

  • Which topic areas would you like to see more coverage of at future congresses? Select all that apply.

  • SECTION 6: WORKSHOPS & SPECIAL SESSIONS

  • Did you attend the Pre-Day sessions on Tuesday March 17?

  • SECTION 7: REGISTRATION & ABSTRACT SUBMISSION

  •

  • SECTION 8: VENUE & LOGISTICS

  • SECTION 9: SOCIAL & NETWORKING EVENTS

  •
  • Were there enough opportunities for networking and informal discussion?

  • SECTION 10: VIRTUAL ATTENDANCE EXPERIENCE

  • The following questions are for virtual attendees only. If you attended in person, please skip to the next section.
  •
  • Did you feel adequately included as a virtual attendee?
  • Should ISOO offer a virtual option at future congresses?

  • SECTION 11: LOOKING AHEAD

  •
  • Interest in mid-cycle programming between congresses such as webinars or smaller focused meetings?
  • Should be Empty: